Literature DB >> 15249377

Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.

Heidi I Becker1, R Christopher Walton, Jonathan I Diamant, Michael E Zegans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15249377     DOI： 10.1001/archopht.122.7.1063

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  7 in total

1.  [Glaucoma and corneal transplantation].

Authors:  G Geerling; M Müller; M Zierhut; T Klink
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution.

Authors:  Alfonso Casado; Carmen Cabarga; Miguel A de la Fuente; Francisco J Muñoz-Negrete
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-09       Impact factor: 3.117

3.  Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.

Authors:  María Alejandra Carrasco; Bernardo Ariel Schlaen; Jorge Oscar Zárate
Journal:  Int Ophthalmol       Date:  2012-12-06       Impact factor: 2.031

4.  Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits.

Authors:  Momoko Nakamura-Shibasaki; Miftahul Akhyar Latief; Ji-Ae Ko; Kunihiko Funaishi; Yoshiaki Kiuchi
Journal:  Jpn J Ophthalmol       Date:  2016-02-02       Impact factor: 2.447

5.  Endoscopic Cyclophotocoagulation Combined with Phacoemulsification Increases Risk of Persistent Anterior Uveitis Compared to Phacoemulsification Surgery Alone.

Authors:  Vivek A Koduri; Amit K Reddy; Jennifer L Patnaik; Alan G Palestine; Anne M Lynch; Mina B Pantcheva
Journal:  Clin Ophthalmol       Date:  2021-02-05

6.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25

7.  The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations.

Authors:  Ruiz Simonato Alonso; Helena Parente Solari; Eduardo de França Damasceno; Miguel Noel Nascentes Burnier; Marcelo Palis Ventura
Journal:  BMC Pharmacol Toxicol       Date:  2020-03-23       Impact factor: 2.483
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.